Covid-19 (Temas de Saúde Pública)
Reduzindo o SARS-CoV-2 em ambientes fechados compartilhados.
14 Jun, 2022 | 13:57hReducing SARS-CoV-2 in Shared Indoor Air – JAMA
Revisão de escopo | Consequências não intencionais das medidas implementadas no ambiente escolar para conter a pandemia de COVID-19.
14 Jun, 2022 | 13:20hResumo: Unintended consequences of school-based measures to manage the COVID-19 pandemic – Cochrane Library
Suplemento | Infecção por Covid-19.
13 Jun, 2022 | 14:22hPágina principal: Covid-19 Infection – Infectious Disease Clinics of North America
Editorial: COVID-19: Where We Are, Where We Need to Be
COVID-19 Pathogenesis and Clinical Manifestations
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
Laboratory Diagnosis for SARS-CoV-2 Infection
Pharmacologic Treatment and Management of Coronavirus Disease 2019
COVID-19 in the Critically Ill Patient
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children
Estudo de coorte | Acurácia diagnóstica da detecção não invasiva de infecção por SARS-CoV-2 feita por cães farejadores.
6 Jun, 2022 | 11:36hDiagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction – PLOS One
Estudo relacionado: Scent dogs in detection of COVID-19: triple-blinded randomised trial and operational real-life screening in airport setting – BMJ Global Health
Comentário no Twitter
The overall sensitivity of Covid detection by trained dogs was 97% and "even reached 100% in asymptomatic individuals" compared to nasopharyngeal swab PCR tests. Overall canine sensitivity vs PCR (97% CI: 91 to 99 versus 84% CI: 74 to 90, p = 0.006), https://t.co/tE2oD6Ecdf pic.twitter.com/uC9hDTH9WM
— Eric Topol (@EricTopol) June 1, 2022
Sob licença de Creative Commons Attribution License
Metanálise em rede | Efetividade dos regimes heterólogos e homólogos de vacinação contra Covid-19.
2 Jun, 2022 | 14:05hComunicado de imprensa: Three doses of the same or mixed covid jabs work equally well against infections – BMJ
Comentário: Three jabs best for preventing Covid infections, global analysis finds – The Guardian
Um sistema de alerta precoce para o surgimento de variantes do SARS-CoV-2.
1 Jun, 2022 | 13:50hAn early warning system for emerging SARS-CoV-2 variants – Nature Medicine
Comentário no Twitter
🆕@NatureMedicine
"The pandemic is not over, and #SARSCoV2 is spreading at a high level globally. Now is the time to enhance global sequencing capacities, focusing on widening coverage to include previous geographical and population blind spots"https://t.co/yL2xisDH0r@lsubissi pic.twitter.com/xip3MR762v— Eric Topol (@EricTopol) May 30, 2022
Análise/Opinião | As consequências não intencionais da política de vacinas contra COVID-19: “pode ser que mandatos, passaportes e restrições causem mais prejuízos que benefícios.”
31 Mai, 2022 | 12:33h
Comentário no Twitter (fio – clique para saber mais)
📢 Our paper on COVID-19 vaccine policy has been published💉🦠
We discuss 12 unintended consequences of mandates and passports across society
& argue that pandemic vaccine policies have caused more social harm than good
Read the paper: https://t.co/TeyTki0nWI pic.twitter.com/BRJQRURbUc
— Kevin Bardosh (@KevinBardosh) May 26, 2022
OMS valida a 11ª vacina contra COVID-19.
23 Mai, 2022 | 13:37hWHO validates 11th vaccine for COVID-19 – World Health Organization
Comentário no Twitter
WHO issued an emergency use listing for CONVIDECIA, a vaccine manufactured by CanSino Biologics, China, adding to a growing portfolio of #COVID19 vaccines validated by WHO https://t.co/QdpHiasT2p pic.twitter.com/2B54FwiNDl
— World Health Organization (WHO) (@WHO) May 19, 2022
Evidência sobre COVID-19: uma coletânea Cochrane.
23 Mai, 2022 | 13:36hCOVID-19 evidence: a Cochrane round-up – Cochrane Library
Covid-19 | OMS afirma que o segundo reforço de vacina pode ser benéfico em grupos de alto risco, mas tem um impacto “mínimo” para outros grupos.
23 Mai, 2022 | 13:31hDiretriz original: Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 – World Health Organization
Recomendações relacionadas: